Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Current Deferred Revenue (2021 - 2025)

Biote (BTMD) has 5 years of Current Deferred Revenue data on record, last reported at $3.2 million in Q3 2025.

  • For Q3 2025, Current Deferred Revenue rose 8.13% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, up 8.13%, while the annual FY2024 figure was $3.0 million, 1.37% down from the prior year.
  • Current Deferred Revenue reached $3.2 million in Q3 2025 per BTMD's latest filing, up from $3.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $3.2 million in Q3 2025 and bottomed at $1.7 million in Q4 2021.
  • Average Current Deferred Revenue over 5 years is $2.6 million, with a median of $2.9 million recorded in 2024.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 52.77% in 2023, then decreased 3.39% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $1.7 million in 2021, then rose by 15.25% to $2.0 million in 2022, then surged by 52.77% to $3.0 million in 2023, then decreased by 1.37% to $3.0 million in 2024, then rose by 6.89% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $3.2 million in Q3 2025, $3.1 million in Q2 2025, and $3.0 million in Q1 2025.